Novel Candidate Tuberculosis Treatment Compound Licensing Agreement Between Calibr and Bill & Melinda Gates Medical Research Institute
by Press Release from Outbreak News Today on (#68X7A)
Calibr, a division of Scripps Research dedicated to the bench to bedside" development of transformative medicines, and the Bill & Melinda Gates Medical Research Institute (Gates MRI), today announced a strategic licensing agreement to advance development of a novel investigational compound for tuberculosis treatment. Under the agreement, Calibr is granting Gates MRI an exclusive license [...]
The post Novel Candidate Tuberculosis Treatment Compound Licensing Agreement Between Calibr and Bill & Melinda Gates Medical Research Institute appeared first on Outbreak News Today.